Researcher Next
Create account
← Back to directory

Alessandra Bearz

Researcher Next ID · RN-013694

Researcher · Medicine

National Cancer Institute

, Ukraine

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
317
Citation count
15,527
H-index
45
i10-index
124

Research interests

Medicine
Lung Cancer Treatments and Mutations
Lung Cancer Research Studies
Lung Cancer Diagnosis and Treatment
Colorectal Cancer Treatments and Studies
Cancer Immunotherapy and Biomarkers

Publications

  • Brigatinib versus Crizotinib in ALK -Positive Non–Small-Cell Lung Cancer

    New England Journal of Medicine · 2018 · 10.1056/nejmoa1810171

  • Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study

    The Lancet Oncology · 2018 · 10.1016/s1470-2045(18)30649-1

  • Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

    The Lancet Oncology · 2017 · 10.1016/s1470-2045(17)30339-x

  • Alectinib in Crizotinib-Refractory ALK-Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Study

    Journal of Clinical Oncology · 2015 · 10.1200/jco.2015.63.9443

  • Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

    The Lancet Oncology · 2012 · 10.1016/s1470-2045(11)70393-x

Current projects

    No projects listed.